Stories about Medizin, Gesundheit
- 2One documentmore
- 6
Press Release - hubergroup is Cradle to Cradle certified for the fourth time in a row
One documentmore Bosch Healthcare Solutions GmbH
Near-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesii
more- 2
PM: DHL Logistics Trend Radar 7.0 beleuchtet neue Entwicklungen in Bereichen wie KI und Nachhaltigkeit / PR: DHL Logistics Trend Radar 7.0 unveils emerging AI trends and sustainable solutions
2 Documentsmore LAUDA DR. R. WOBSER GMBH & CO. KG
Dr. Ralf Hermann ends career at LAUDA
morecanSERV relaunches Open Call for Service Provision
One documentmore
Press release: STADA continues strong growth journey in the first half of 2024
One documentmore- 4
Ottobock in top form – a year full of highlights
more Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
moreLONGi Green Energy Technology Co., Ltd.
Solar Partners Aid Newborns and Mothers in Africa with Solar-Powered Freshwater Solution
moreGermany Attracts Another Billion-Euro Pharma Project
Berlin (ots) - French pharmaceutical giant Sanofi has confirmed it will invest 1.3 billion euros to expand insulin production in the western German city of Frankfurt am Main. Sanofi says the expansion will encompass around 36,000 square meters – the equivalent of five football fields – on the company’s existing BioCampus site. It will go operational in 2029. The project is being supported by the German national ...
moreGrünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®
Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...
more
Bosch Healthcare Solutions GmbH
PCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling point
moreFitLine becomes Official Partner of the ATP Tour
more- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
more Virchow Foundation for Global Health
2Lucy Gilson and Johan Rockström awarded the Virchow Prize 2024
more- 4
Ottobock: A family business continues to grow / Expansion in Scandinavia
more canSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 Documentsmore
LAUDA DR. R. WOBSER GMBH & CO. KG
Special Honor for Itzik Avni from Israel
more- 10
Gerresheimer: New pictures available
more LAUDA DR. R. WOBSER GMBH & CO. KG
Lauda Technology Sets Standards in Plant Engineering
moreLAUDA DR. R. WOBSER GMBH & CO. KG
5ACHEMA 2024: LAUDA Looks Back on a Successful Exhibition
more- 4
Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science Prizes
One documentmore Press release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
One documentmore
Bayer Collaborates with PAPACKS to Co-create Alternative-to-Plastic Packaging for Consumer Health Products
moreNew Study: Father's Diet Before Conception Influences Children's Health
morePress release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo
STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...
One documentmorePress Release: Restless Legs Syndrome: Genetic Discoveries Advance Treatment and Risk Prediction
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) together with international collaborators have conducted the largest genetic investigation of the restless legs syndrome to date. Their findings, ...
morePM: DHL Supply Chain erweitert Pharmalogistik-Geschäft in Frankreich / PR: DHL Supply Chain expands pharma logistics operations in France
more- 2
PM: IATA CEIV Pharma Certification für DHL Global Forwarding / PR: IATA CEIV Pharma Certification for DHL Global Forwarding
2 Documentsmore